Vedolizumab Post Op Study

NCT02834754 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Limited time for enrollment of required number of subjects

Conditions

Crohn's Disease

Interventions

DRUG: Vedolizumab
DRUG: placebo

Sponsor

Marc Schwartz

Collaborators

[object Object]